Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Epoetin Beta (NeoRecormon®) in Anemic Participants With Breast Cancer Undergoing Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy and safety of epoetin beta (NeoRecormon) for anemia in breast cancer patients undergoing chemotherapy has completed with poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Breast Cancer

Drugs mentioned

• NeoRecormon (epoetin beta)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 2 | Status: COMPLETED | Results posted: 2018-08-24